Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy

Fiona McInnes, Nicola Clear, Gerry James, Howard N.E. Stevens, Unai Vivanco, Michael Humphrey

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The aim of this study was to evaluate clearance from the buccal cavity and pharmacokinetic profiles of a sublingual spray formulation in the dog, to assist in interpretation of future pharmacokinetic studies. Radiolabelled buprenorphine in a spray formulation (400 μg/100 μl in 30% ethanol) was administered sublingually to four beagle dogs, and the residence in the oral cavity was determined using gamma scintigraphy. Pharmacokinetic sampling was performed to facilitate correlation of location of dose with significant pharmacokinetic events. Scintigraphic imaging revealed that clearance of the formulation from the oral cavity was rapid, with a mean T 50% clearance of 0.86 ± 0.46 min, and T 80% clearance of 2.75 ± 1.52 min. In comparison, absorption of buprenorphine was relatively slow, with a T max of 0.56 ± 0.13 h. Good buccal absorption despite short residence time can be explained by lipophilicity of buprenorphine enabling rapid sequestration into the oral mucosa, prior to diffusion and absorption directly into systemic circulation. This study demonstrated rapid clearance of a sublingual solution from the canine oral cavity, with T 50% similar to results previously reported in man, providing initial confidence in using a conscious dog model to achieve representative residence times for a sublingual solution.
LanguageEnglish
Pages869-874
Number of pages5
JournalPharmaceutical Research
Volume25
Issue number4
DOIs
Publication statusPublished - 2008

Fingerprint

Buprenorphine
Pharmacokinetics
Radionuclide Imaging
Dogs
Mouth
Cheek
Mouth Mucosa
Canidae
Ethanol
Sampling
Imaging techniques

Keywords

  • buccal
  • buprenorphine
  • gamma scintigraphy
  • sublingual
  • pharmacology
  • biomedical sciences

Cite this

McInnes, Fiona ; Clear, Nicola ; James, Gerry ; Stevens, Howard N.E. ; Vivanco, Unai ; Humphrey, Michael. / Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy. In: Pharmaceutical Research. 2008 ; Vol. 25, No. 4. pp. 869-874.
@article{bdfdce6adfed4ecaab32dd635441b56e,
title = "Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy",
abstract = "The aim of this study was to evaluate clearance from the buccal cavity and pharmacokinetic profiles of a sublingual spray formulation in the dog, to assist in interpretation of future pharmacokinetic studies. Radiolabelled buprenorphine in a spray formulation (400 μg/100 μl in 30{\%} ethanol) was administered sublingually to four beagle dogs, and the residence in the oral cavity was determined using gamma scintigraphy. Pharmacokinetic sampling was performed to facilitate correlation of location of dose with significant pharmacokinetic events. Scintigraphic imaging revealed that clearance of the formulation from the oral cavity was rapid, with a mean T 50{\%} clearance of 0.86 ± 0.46 min, and T 80{\%} clearance of 2.75 ± 1.52 min. In comparison, absorption of buprenorphine was relatively slow, with a T max of 0.56 ± 0.13 h. Good buccal absorption despite short residence time can be explained by lipophilicity of buprenorphine enabling rapid sequestration into the oral mucosa, prior to diffusion and absorption directly into systemic circulation. This study demonstrated rapid clearance of a sublingual solution from the canine oral cavity, with T 50{\%} similar to results previously reported in man, providing initial confidence in using a conscious dog model to achieve representative residence times for a sublingual solution.",
keywords = "buccal, buprenorphine, gamma scintigraphy, sublingual, pharmacology, biomedical sciences",
author = "Fiona McInnes and Nicola Clear and Gerry James and Stevens, {Howard N.E.} and Unai Vivanco and Michael Humphrey",
year = "2008",
doi = "10.1007/s11095-007-9423-0",
language = "English",
volume = "25",
pages = "869--874",
journal = "Pharmaceutical Research",
issn = "0724-8741",
number = "4",

}

Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy. / McInnes, Fiona; Clear, Nicola; James, Gerry; Stevens, Howard N.E.; Vivanco, Unai; Humphrey, Michael.

In: Pharmaceutical Research, Vol. 25, No. 4, 2008, p. 869-874.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy

AU - McInnes, Fiona

AU - Clear, Nicola

AU - James, Gerry

AU - Stevens, Howard N.E.

AU - Vivanco, Unai

AU - Humphrey, Michael

PY - 2008

Y1 - 2008

N2 - The aim of this study was to evaluate clearance from the buccal cavity and pharmacokinetic profiles of a sublingual spray formulation in the dog, to assist in interpretation of future pharmacokinetic studies. Radiolabelled buprenorphine in a spray formulation (400 μg/100 μl in 30% ethanol) was administered sublingually to four beagle dogs, and the residence in the oral cavity was determined using gamma scintigraphy. Pharmacokinetic sampling was performed to facilitate correlation of location of dose with significant pharmacokinetic events. Scintigraphic imaging revealed that clearance of the formulation from the oral cavity was rapid, with a mean T 50% clearance of 0.86 ± 0.46 min, and T 80% clearance of 2.75 ± 1.52 min. In comparison, absorption of buprenorphine was relatively slow, with a T max of 0.56 ± 0.13 h. Good buccal absorption despite short residence time can be explained by lipophilicity of buprenorphine enabling rapid sequestration into the oral mucosa, prior to diffusion and absorption directly into systemic circulation. This study demonstrated rapid clearance of a sublingual solution from the canine oral cavity, with T 50% similar to results previously reported in man, providing initial confidence in using a conscious dog model to achieve representative residence times for a sublingual solution.

AB - The aim of this study was to evaluate clearance from the buccal cavity and pharmacokinetic profiles of a sublingual spray formulation in the dog, to assist in interpretation of future pharmacokinetic studies. Radiolabelled buprenorphine in a spray formulation (400 μg/100 μl in 30% ethanol) was administered sublingually to four beagle dogs, and the residence in the oral cavity was determined using gamma scintigraphy. Pharmacokinetic sampling was performed to facilitate correlation of location of dose with significant pharmacokinetic events. Scintigraphic imaging revealed that clearance of the formulation from the oral cavity was rapid, with a mean T 50% clearance of 0.86 ± 0.46 min, and T 80% clearance of 2.75 ± 1.52 min. In comparison, absorption of buprenorphine was relatively slow, with a T max of 0.56 ± 0.13 h. Good buccal absorption despite short residence time can be explained by lipophilicity of buprenorphine enabling rapid sequestration into the oral mucosa, prior to diffusion and absorption directly into systemic circulation. This study demonstrated rapid clearance of a sublingual solution from the canine oral cavity, with T 50% similar to results previously reported in man, providing initial confidence in using a conscious dog model to achieve representative residence times for a sublingual solution.

KW - buccal

KW - buprenorphine

KW - gamma scintigraphy

KW - sublingual

KW - pharmacology

KW - biomedical sciences

UR - http://dx.doi.org/10.1007/s11095-007-9423-0

U2 - 10.1007/s11095-007-9423-0

DO - 10.1007/s11095-007-9423-0

M3 - Article

VL - 25

SP - 869

EP - 874

JO - Pharmaceutical Research

T2 - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 4

ER -